Page last updated: 2024-08-25

doripenem and Ventilator-Associated Pneumonia

doripenem has been researched along with Ventilator-Associated Pneumonia in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (33.33)	29.6817
2010's	16 (59.26)	24.3611
2020's	2 (7.41)	2.80

Authors

Authors	Studies
Bruno, CJ; Kollef, MH; Réa-Neto, Á; Rhee, EG; Wunderink, RG	1
Lai, CC; Tang, HJ	1
Aubry, A; Bréchot, N; Brossier, F; Jarlier, V; Lu, Q; Luyt, CE; Micaëlo, M; Monsel, A	1
Chuang, YC; Liu, WD; Sheng, WH; Shih, MC; Wang, JT	1
Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M	1
Davies, TA; He, W; Lynch, AS; Queenan, AM	1
Aubry, A; Bréchot, N; Brisson, H; Brossier, F; Chastre, J; Combes, A; Jarlier, V; Lu, Q; Luyt, CE; Micaelo, M; Rouby, JJ; Trouillet, JL	1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N	1
Aubry, A; Chastre, J; Crandon, JL; Luyt, CE; Nicolau, DP	1
Badal, RE; Biedenbach, DJ; Giao, PT; Hung Van, P; Phuong, DM; Su Minh Tuyet, N; Thi Thanh Nga, T; Vu Trung, N	1
Goff, DA; Mangino, JE; Schafer, JJ	1
Restrepo, MI	1
File, TM; Redman, R	1
Amin, A	1
Akhras, K; DeLong, K; Ingham, M; McGarry, LJ; Merchant, S; Nathwani, D; Pawar, V; Thompson, D; Weinstein, MC	1
Gast, C; Ketter, N; Kollef, MH; Merchant, S; Nathwani, D; Quintana, A	1
Chen, J; Mody, SH; Shorr, AF; Zilberberg, MD	1
Apisarnthanarak, A; Mundy, LM	1
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA	1
Aeinlang, N; Jaruratanasirikul, S; Jullangkoon, M; Kositpantawong, N; Wongpoowarak, W	1
Chastre, J; Cirillo, I; Clavel, M; Kaniga, K; Kimko, H; Kollef, MH; Michiels, B; Redman, R; Restrepo, MI	1
Chastre, J; Friedland, I; Kaniga, K; Lee, M; Prokocimer, P; Wunderink, R	1
Gilbert, D	1
Friedland, I; Gast, C; Ingham, M; Ketter, N; Lee, M; Merchant, S; Nathwani, D; Quintana, A	1

Reviews

1 review(s) available for doripenem and Ventilator-Associated Pneumonia

Article	Year
Doripenem: a new addition to the carbapenem class of antimicrobials. Recent patents on anti-infective drug discovery, 2009, Volume: 4, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2009

Trials

7 trial(s) available for doripenem and Ventilator-Associated Pneumonia

Article	Year
Imipenem, meropenem, or doripenem to treat patients with Pseudomonas aeruginosa ventilator-associated pneumonia. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Thienamycins	2014
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study). International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult	2014
Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia. International journal of antimicrobial agents, 2012, Volume: 40, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors	2012
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Critical care (London, England), 2012, Nov-13, Volume: 16, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Doripenem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Ventilator-Associated; Young Adult	2012
Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Critical care medicine, 2008, Volume: 36, Issue:4 Topics: Aged; Anti-Bacterial Agents; APACHE; Carbapenems; Doripenem; Female; Hospital Mortality; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Treatment Outcome	2008
"The truth, if it exists, is in the details". Critical care medicine, 2008, Volume: 36, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Doripenem; Humans; Imipenem; Pneumonia, Ventilator-Associated; Severity of Illness Index; Treatment Outcome	2008
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia. Clinical therapeutics, 2008, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Costs and Cost Analysis; Doripenem; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospital Costs; Humans; Imipenem; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Ventilator-Associated; Survival Rate; Treatment Outcome	2008

Other Studies

19 other study(ies) available for doripenem and Ventilator-Associated Pneumonia

Article	Year
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply. The Lancet. Infectious diseases, 2020, Volume: 20, Issue:1 Topics: Cephalosporins; Cross Infection; Doripenem; Double-Blind Method; Humans; Meropenem; Pneumonia, Ventilator-Associated; Tazobactam	2020
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia. The Lancet. Infectious diseases, 2020, Volume: 20, Issue:1 Topics: Cephalosporins; Cross Infection; Doripenem; Double-Blind Method; Humans; Meropenem; Pneumonia, Ventilator-Associated; Tazobactam	2020
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa. Medecine et maladies infectieuses, 2018, Volume: 48, Issue:5 Topics: beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Reagent Strips; Sensitivity and Specificity	2018
Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:5 Topics: Acinetobacter baumannii; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Regression Analysis; Retrospective Studies; Taiwan	2019
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome	2013
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients. Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis	2013
Pharmacodynamics of carbapenems for the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia: associations with clinical outcome and recurrence. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; Disk Diffusion Antimicrobial Tests; Doripenem; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Thienamycins; Treatment Outcome	2016
Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam. Clinical therapeutics, 2016, Volume: 38, Issue:9 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gentamicins; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Tigecycline; Vietnam	2016
Efficacy of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Ventilator-Associated	2009
Safety of intravenous infusion of doripenem. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control	2009
Clinical and economic consequences of ventilator-associated pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Health Care Costs; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Length of Stay; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Severity of Illness Index	2009
Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia. Journal of medical economics, 2010, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cost-Benefit Analysis; Decision Support Techniques; Doripenem; Hospitalization; Humans; Imipenem; Intensive Care Units; Length of Stay; Middle Aged; Models, Economic; Monte Carlo Method; Pneumonia, Ventilator-Associated; Probability; Respiration, Artificial; Time Factors; United States	2010
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators. Critical care (London, England), 2010, Volume: 14, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Female; Health Resources; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome	2010
Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia. Surgical infections, 2010, Volume: 11, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost-Benefit Analysis; Doripenem; Drug Combinations; Humans; Imipenem; Length of Stay; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Young Adult	2010
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors	2012
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic	2012
Doripenem: excess mortality. Prescrire international, 2012, Volume: 21, Issue:130 Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Doripenem; Drug Combinations; Early Termination of Clinical Trials; Evidence-Based Medicine; Humans; Imipenem; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome	2012
Doripenem (Doribax)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2008, Jan-28, Volume: 50, Issue:1278 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Drug Administration Schedule; Drug Interactions; Humans; Infusions, Intravenous; Pneumonia, Ventilator-Associated; Treatment Outcome; Urinary Tract Infections	2008
Doripenem (doribax)--a new parenteral carbapenem. Obstetrics and gynecology, 2008, Volume: 111, Issue:5 Topics: Carbapenems; Cross Infection; Doripenem; Female; Humans; Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2008